Patients with diabetes in the intensive care unit; not served by treatment, yet protected? by Siegelaar, Sarah E et al.
As reported in the previous issue of Critical Care, Vincent 
and colleagues [1] investigated the possible increased risk 
of patients with insulin-treated diabetes for morbidity and 
mortality in the intensive care unit (ICU). Literature is 
conﬂ  icting at this point, with studies showing increased 
risk [2,3], decreased risk [4], or neutral risk [5,6]. In their 
analyses, Vincent and colleagues included 3,147 patients 
originally recruited for the Sepsis Occurrence in Acutely ill 
Patients (SOAP) study [7], including 226 (7.2%) patients 
with a prior diagnosis of insulin-treated diabetes. No 
signiﬁ  cant diﬀ  erences in ICU or 28-day hospital mortality 
were observed between the groups, even though patients 
with insulin-treated diabetes were sicker at baseline, as 
reﬂ   ected by higher Simpliﬁ   ed Acute Physiology Score 
(SAPS II) and Sequential Organ Failure Assessment 
(SOFA) score. From a Cox proportional hazards analysis 
correcting for diﬀ   erences in patient characteristics, it 
appeared that patients with insulin-treated diabetes were 
more likely to develop renal failure, but diabetes was not 
an indepen  dent predictor of ICU or 28-day mortality 
(hazard ratio 0.78, conﬁ   dence interval 0.58 to 1.07, 
P = 0.12). Patients were followed until death or hospital 
discharge or for 60 days. Th  e latter mortality rates were 
not discussed, probably due to low numbers in the diabetes 
group at 60 days.
Th  e diabetes population in the study of Vincent and 
colleagues consisted only of patients with a history of 
insulin-treated diabetes. Th  is  deﬁ  nition does not classify 
between type 1 and type 2 diabetes, and from the large 
type 2 diabetes population, only the insulin-treated pro-
por  tion, around 25% of all type 2 diabetes patients, is 
captured. How this aﬀ  ects the conclusions is unknown. 
Also, the authors did not have the opportunity to collect 
data with respect to glucose regulation or insulin therapy, 
and this might have contributed to observed group 
diﬀ  erences.
Vincent and colleagues do not stand alone in their 
conclusions. Very recent descriptions of two large mixed 
ICU populations [4] and, more speciﬁ  cally, sepsis patients 
[6] also found no diﬀ  erences in mortality, and perhaps 
even less mortality, in diabetes compared with non-
diabetes patients, despite larger morbidity in the former 
group. Larger morbidity and development of 
complications in diabetes can be explained by the often 
pre-existing organ dysfunction and pathophysiological 
alterations in the disease. Th  is raises the intriguing 
question of how patients with diabetes manage to survive 
in the ICU despite an increased risk for a variety of 
complications such as bloodstream infections [6,8] and 
renal failure [1], which are, at least in the non-diabetic 
population, independently associated with mortality 
[9,10]. Remarkably, there seems to be a lower incidence 
of acute lung injury in patients with diabetes [11].
Th  ere may be two sides to the diabetes coin. Th  ere is 
evidence that hyperglycemia caused by critical illness is 
not associated with mortality in patients with diabetes 
[6,12,13], but on the other hand, patients with diabetes 
do not seem to beneﬁ  t from intensive insulin therapy 
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hyperglycemia in critical illness and hyperglycemia due 
to chronic diabetes are two distinct pathophysiological 
entities. Perhaps this is a call for an active search for pre-
existing diabetes since this is often undiagnosed at the 
time of an event leading to hospital admission.
Various mechanisms are proposed to explain the 
similar outcomes of patients with diabetes and those 
without it. Insulin may protect through anti-inﬂ  am  ma-
tory eﬀ  ects [15] given that in the intensive insulin therapy 
era, many patients without diabetes are receiving insulin. 
Also, a higher body mass index may have a protective 
eﬀ  ect against ICU mortality and may also protect people 
with type 2 diabetes [16]. Adaptation to hyperglycemia 
might be a key mechanism. Oxidative stress, arising from 
inﬂ   am  mation and hyperglycemia, is known to cause 
endothelial damage through several mechanisms and is 
associated with poor outcome in the critically ill [17]. It is 
possible that because diabetes patients are already 
adapted to oxidative stress due to previous chronic 
exposure to hyperglycemia, the critical illness-induced 
oxidative stress is more harmful to non-diabetic patients 
because they have not yet activated cellular adaptation 
mechanisms.
Whatever the mechanism is, this elegant study by 
Vincent and colleagues contributes to the evidence that 
diabetes itself is not a risk factor for mortality in the ICU. 
Moreover, the likely higher complication and morbidity 
rates of patients with diabetes and diﬀ  erent responses to 
hyperglycemia suggest the need for the implementation 
of diﬀ  erent treatment algorithms for both groups.
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